Medchemexpress LLC MTI-31 | 1567915-38-1 | 100.0% | 474.55 | C26H30N6O3 | 1MG

Supplier:  Medchemexpress LLC HY1260771MG

MTI-31 (LXI-15029) is a potent, orally active, and highly selective inhibitor of mTORC1 and mTORC2 used in preclinical cancer research. It demonstrates strong biochemical potency and in vivo efficacy in tumor models, with formulation and storage guidance for laboratory use.

• Potent, selective inhibition of mTORC1 and mTORC2.
• High binding affinity for mTOR (Kd 0.20 nM) and low biochemical IC50 (39 nM).
• High purity and consistent solid appearance for reproducible results.
• Soluble in DMSO and compatible with common in vivo formulations.
• Stable as powder at low temperatures and in solvent with recommended storage conditions.
• Molecular formula C26H30N6O3 and molecular weight 474.55.

Catalog No. 50-002-35106